-
15477-1A metabolite of the immunosuppressant drug cyclosporin A that displays about 10% lower immunosuppressant activity than cyclosporin A used as an internal standard for the quantification of cyclosporin A.
-
15477-5A metabolite of the immunosuppressant drug cyclosporin A that displays about 10% lower immunosuppressant activity than cyclosporin A used as an internal standard for the quantification of cyclosporin A.
-
17182-1A natural cyclic undecapeptide that selectively antagonizes the formyl peptide receptor at concentrations ranging from 0.1 to 10 µM.
-
17182-5A natural cyclic undecapeptide that selectively antagonizes the formyl peptide receptor at concentrations ranging from 0.1 to 10 µM.
-
16335-10A benzothiadiazide that acts as a potentiator of AMPA receptors, positively modulating its response to glutamic acid (EC<sub>50</sub> = 3.8 µM) also a negative modulator of GABAA receptors, reversibly inhibiting both evoked and spontaneous
-
16335-100A benzothiadiazide that acts as a potentiator of AMPA receptors, positively modulating its response to glutamic acid (EC<sub>50</sub> = 3.8 µM) also a negative modulator of GABAA receptors, reversibly inhibiting both evoked and spontaneous
-
16335-25A benzothiadiazide that acts as a potentiator of AMPA receptors, positively modulating its response to glutamic acid (EC<sub>50</sub> = 3.8 µM) also a negative modulator of GABAA receptors, reversibly inhibiting both evoked and spontaneous
-
16335-50A benzothiadiazide that acts as a potentiator of AMPA receptors, positively modulating its response to glutamic acid (EC<sub>50</sub> = 3.8 µM) also a negative modulator of GABAA receptors, reversibly inhibiting both evoked and spontaneous
-
10007867-100A cyanobacterial toxin that targets protein and glutathione synthesis in hepatocytes (IC50s = 1.3 and 2.4 µM, respectively), inhibits uridine monophosphate synthase complex activity (Ki = 10 µM), and induces DNA damage.
-
10007867-25A cyanobacterial toxin that targets protein and glutathione synthesis in hepatocytes (IC50s = 1.3 and 2.4 µM, respectively), inhibits uridine monophosphate synthase complex activity (Ki = 10 µM), and induces DNA damage.
-
10007867-50A cyanobacterial toxin that targets protein and glutathione synthesis in hepatocytes (IC50s = 1.3 and 2.4 µM, respectively), inhibits uridine monophosphate synthase complex activity (Ki = 10 µM), and induces DNA damage.
-
14667-1A novel agonist of SIP4 (EC<sub>50</sub> = 56 nM) that displays 37-fold selectivity against S1P5 (EC<sub>50</sub> = 2.1 &muM) and no appreciable activity over the S1P1-3 subtypes at concentrations up to 25 &muM.